New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 19, 2012
06:50 EDTARNAArena Pharmaceuticals option implied volatility is low
Arena Pharmaceuticals option implied volatility is low, near the bottom of its 52-week range according to iVolatility.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
08:18 EDTARNAArena press release lacking key data, TheStreet's Feuerstein says
Subscribe for More Information
October 28, 2014
18:25 EDTARNAArena Pharmaceuticals, Eisai study meets primary safety objective
Eisai and Arena Pharmaceuticals announced top-line results of a pilot study to assess the safety of lorcaserin HCl, a serotonin 2C receptor agonist, when coadministered with phentermine HCl. The results of the investigational study demonstrate that the short-term combination of lorcaserin plus phentermine does not appear to be associated with an exacerbation in the proportion of pre-specified adverse events compared to therapy with lorcaserin alone. The coadministration of lorcaserin and phentermine for weight management is investigational. The efficacy and safety of coadministration of lorcaserin and other weight loss products such as phentermine have not been established.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use